Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Courouce

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Vox Sanguinis|September 1, 1970
Study of the Australia antigen and of the corresponding antibody in blood donors in ParisJ P Soulier, A M Courouce-Pauty, D Benamon-Djiane
Arthritis and Rheumatism|April 1, 1986
Human parvovirus arthropathyM Dougados, B Amor, J J Lefrere, et al.
Presse Medicale (Paris, France : 1983)|February 2, 1985
[Erythroblastopenia and febrile meningeal syndrome caused by parvovirus in a child homozygotic for sickle cell anemia]J Lefrere, C Olivier, A M Courouce, et al.
The Journal of Infection|July 1, 1986
Human parvovirus and thalassaemiaJ J Lefrere, A M Courouce, R Girot, et al.
Archives Francaises De Pediatrie|October 1, 1987
[Parvovirus B19 and the fifth disease]T Lacaze, Y de Prost, J J Lefrère, et al.
Presse Medicale (Paris, France : 1983)|June 28, 1986
[Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody]V Thiers, F Bouchardeau, A M Courouce, et al.
The New England Journal of Medicine|December 6, 1984
Hepatitis B vaccine in dialysis patientsA M Courouce, P Jungers, E Benhamou, et al.
Lancet (London, England)|January 23, 1982
Responses to hepatitis B vaccineA Laplanche, A M Courouce, E Benhamou, et al.
Lancet (London, England)|October 13, 1984
Hepatitis B vaccination: how long does protection last?A Laplanche, A M Courouce, P Jungers, et al.
Annales De Pediatrie|May 1, 1986
[Vascular purpura associated with an infection caused by human parvovirus]J J Lefrere, A M Courouce, M Briand, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Vox Sanguinis|September 1, 1970
Study of the Australia antigen and of the corresponding antibody in blood donors in ParisJ P Soulier, A M Courouce-Pauty, D Benamon-Djiane
Arthritis and Rheumatism|April 1, 1986
Human parvovirus arthropathyM Dougados, B Amor, J J Lefrere, et al.
Presse Medicale (Paris, France : 1983)|February 2, 1985
[Erythroblastopenia and febrile meningeal syndrome caused by parvovirus in a child homozygotic for sickle cell anemia]J Lefrere, C Olivier, A M Courouce, et al.
The Journal of Infection|July 1, 1986
Human parvovirus and thalassaemiaJ J Lefrere, A M Courouce, R Girot, et al.
Archives Francaises De Pediatrie|October 1, 1987
[Parvovirus B19 and the fifth disease]T Lacaze, Y de Prost, J J Lefrère, et al.
Presse Medicale (Paris, France : 1983)|June 28, 1986
[Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody]V Thiers, F Bouchardeau, A M Courouce, et al.
The New England Journal of Medicine|December 6, 1984
Hepatitis B vaccine in dialysis patientsA M Courouce, P Jungers, E Benhamou, et al.
Lancet (London, England)|January 23, 1982
Responses to hepatitis B vaccineA Laplanche, A M Courouce, E Benhamou, et al.
Lancet (London, England)|October 13, 1984
Hepatitis B vaccination: how long does protection last?A Laplanche, A M Courouce, P Jungers, et al.
Annales De Pediatrie|May 1, 1986
[Vascular purpura associated with an infection caused by human parvovirus]J J Lefrere, A M Courouce, M Briand, et al.
Pageof 11